Berkshire Asset Management LLC Immunity Bio, Inc. Transaction History

Berkshire Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.68 - $6.14 $40,200 - $92,100	-15,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $28,350 - $50,900	-5,000 Reduced 25.0%	15,000 $91,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $67,050 - $112,000	5,000 Added 33.33%	20,000 $286,000
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $192,450 - $633,750	15,000 New	15,000 $356,000

215

63.3M

1.44M

4.12M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $2.09B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Berkshire Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Berkshire Asset Management LLC with notifications on news.